These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26301700)
1. Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery. Luo Y; Wang X; Du D; Lin Y Biomater Sci; 2015 Oct; 3(10):1386-94. PubMed ID: 26301700 [TBL] [Abstract][Full Text] [Related]
2. Apoferritin as an ubiquitous nanocarrier with excellent shelf life. Dostalova S; Vasickova K; Hynek D; Krizkova S; Richtera L; Vaculovicova M; Eckschlager T; Stiborova M; Heger Z; Adam V Int J Nanomedicine; 2017; 12():2265-2278. PubMed ID: 28392686 [TBL] [Abstract][Full Text] [Related]
3. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes. Choi KM; Jang M; Kim JH; Ahn HJ Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094 [TBL] [Abstract][Full Text] [Related]
4. pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect. Fan X; Zhao X; Qu X; Fang J Int J Pharm; 2015 Dec; 496(2):644-53. PubMed ID: 26529576 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-modified multiwalled carbon nanotubes for targeted delivery of doxorubicin into cancer cells. Cao X; Tao L; Wen S; Hou W; Shi X Carbohydr Res; 2015 Mar; 405():70-7. PubMed ID: 25500334 [TBL] [Abstract][Full Text] [Related]
6. Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Chen D; Lian S; Sun J; Liu Z; Zhao F; Jiang Y; Gao M; Sun K; Liu W; Fu F Drug Deliv; 2016; 23(3):808-13. PubMed ID: 24892632 [TBL] [Abstract][Full Text] [Related]
7. Apoferritin nanocages with Au nanoshell coating as drug carrier for multistimuli-responsive drug release. Li M; Wu D; Chen Y; Shan G; Liu Y Mater Sci Eng C Mater Biol Appl; 2019 Feb; 95():11-18. PubMed ID: 30573231 [TBL] [Abstract][Full Text] [Related]
8. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronic Acid-Based pH-Sensitive Polymer-Modified Liposomes for Cell-Specific Intracellular Drug Delivery Systems. Miyazaki M; Yuba E; Hayashi H; Harada A; Kono K Bioconjug Chem; 2018 Jan; 29(1):44-55. PubMed ID: 29183110 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid for anticancer drug and nucleic acid delivery. Dosio F; Arpicco S; Stella B; Fattal E Adv Drug Deliv Rev; 2016 Feb; 97():204-36. PubMed ID: 26592477 [TBL] [Abstract][Full Text] [Related]
11. An insight on hyaluronic acid in drug targeting and drug delivery. Yadav AK; Mishra P; Agrawal GP J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931 [TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304 [TBL] [Abstract][Full Text] [Related]
13. Hydroxychloroquine loaded hollow apoferritin nanocages for cancer drug repurposing and autophagy inhibition. Fang X; Zeng J; Li Y; Yu H; Wu Z; Qi X Eur J Pharm Biopharm; 2024 Oct; 203():114473. PubMed ID: 39186959 [TBL] [Abstract][Full Text] [Related]
14. A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate-apoferritin-conjugated cationic solid lipid nanoparticles. Amer Ridha A; Kashanian S; Rafipour R; Hemati Azandaryani A; Zhaleh H; Mahdavian E Pharm Dev Technol; 2021 Jul; 26(6):673-681. PubMed ID: 33896342 [TBL] [Abstract][Full Text] [Related]
15. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570 [TBL] [Abstract][Full Text] [Related]
16. Layer-by-layer nanoparticle platform for cancer active targeting. Suh MS; Shen J; Kuhn LT; Burgess DJ Int J Pharm; 2017 Jan; 517(1-2):58-66. PubMed ID: 27923697 [TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. Yang H; Bremner DH; Tao L; Li H; Hu J; Zhu L Carbohydr Polym; 2016 Jan; 135():72-8. PubMed ID: 26453853 [TBL] [Abstract][Full Text] [Related]
18. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution. Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562 [TBL] [Abstract][Full Text] [Related]
19. Apoferritin nanocages for targeted delivery of idarubicin against breast cancer cells. Rafipour R; Mousavi A; Mansouri K Biotechnol Appl Biochem; 2022 Jun; 69(3):1061-1067. PubMed ID: 33929766 [TBL] [Abstract][Full Text] [Related]
20. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]